MCDTR Pilot and Feasibility

2021 MCDTR Pilot and Feasibility Grant Program

This Pilot and Feasibility (P/F) Grant Program is sponsored by the Michigan Center for Diabetes Translational Research (MCDTR).  Its purpose is to promote research in diabetes by new and established investigators at the University of Michigan and the University of North Carolina at Chapel Hill. The ultimate goal of the program is to accelerate the pace of research and enable awardees to generate sufficient preliminary data for successful applications for major research funding from the NIH or other national granting agency.

Grant proposals should focus on type 2 translational research and address key questions related to the prevention or treatment of diabetes, its complications, or related endocrine or metabolic disorders (for example; obesity or metabolic syndrome).  Type 2 translational research projects should focus on the translation of research advances into widespread clinical or community practice. This may include the identification of barriers to widespread adoption of new science and the testing of interventions to overcome those barriers. Research may also focus on topics related to social determinants of health and health equity.

Individuals who have instructional, research, or clinical faculty positions at the University of Michigan and the University of North Carolina at Chapel Hill are eligible to apply as Principal Investigators for P/F proposals.  Eligible applicants are: a) new investigators beginning careers in diabetes-related research; b) established investigators who have not previously worked in diabetes research but wish to focus their expertise on diabetes; or c) established diabetes investigators who propose innovative research in diabetes that represents a clear departure from their ongoing research.  This new direction cannot be an extension or outgrowth of research currently being undertaken by the applicant.  Priority will be given to applications from early-stage investigators beginning careers in diabetes-related translational research.

P/F proposals should be for one year of support, with requested funding up to $50,000 direct costs

Each proposal will receive extramural peer review by recognized experts in the area of the proposal. Funding of P/F grants that receive favorable review is anticipated to begin August 2, 2021. 

P/F grant awardees are queried annually by the MCDTR administrative staff and are required to provide information on the publications and funding that stem from the P/F grant as this information must be reported to NIH. P/F grant awardees are also expected to present their research at our Annual MCDTR Diabetes Symposium generally held each year in the spring.

Application Due Date: Tuesday, April 6, 2021 (11:59 PM)

To apply, go to Competition Space.

Download the P/F Application and other Required Application Materials located on the right-hand side of the page (Competition Files). The P/F Application file contains detailed instructions.

When you are ready to submit your application, select “Apply” from the right-hand menu in this Competition Space. Log in with your uniqname and Level 1 (Kerberos) password.

All details are automatically saved as you enter them. When you are ready to submit, click "Submit Application" at the bottom of the page. You will receive a confirmation email once your application has been submitted.

Questions: Contact Pam Campbell, 734-763-5730, pamcamp@umich.edu

Key Personnel

William H. Herman, MD, MPH

Director, MCDTR

Michele E. Heisler, MD, MPA

Co-Director, MCDTR

Pamela A. Campbell

Administrative Specialist Associate